DEAD

Serial Number

90701405

Owner

Reistone Biopharma, Inc.

Attorney

Jessica R. Manganello

Filing Date

May 10, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

REISTONE BIOPHARMA Trademark

Serial Number: 90701405

REISTONE BIOPHARMA is a trademark filed by Reistone Biopharma, Inc. on May 10, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Reistone Biopharma, Inc. (4 trademarks)

Suite 310
Rosemont, IL 60018

Entity Type: 03

Legal Representation

Attorney of Record

Jessica R. Manganello

260 trademarks filed View all →

Trademark Details

Filing Date

May 10, 2021

Registration Date

Not Registered

Published for Opposition

October 25, 2022

Goods & Services

Chemical preparations for pharmaceutical or medical purposes, namely, for treatment and prevention of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of auto immune, immune system, dermatological, and gastroenterological related diseases and disorders; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of auto immune, immune system, dermatological, and gastroenterological related diseases and disorders; Therapeutic pharmaceutical for the treatment of autoimmune, immune system, dermatological, and gastroenterological related diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Jul 24, 2023 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Jul 24, 2023 ABN6

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 20, 2022 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 25, 2022 NPUB

PUBLISHED FOR OPPOSITION

Oct 25, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 5, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 19, 2022 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 10, 2022 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 10, 2022 CRFA

ASSIGNED TO LIE

Aug 9, 2022 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 18, 2022 TROA

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jul 18, 2022 CHAN

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 18, 2022 TCCA

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jul 18, 2022 COAR

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 19, 2022 GNRN

NON-FINAL ACTION E-MAILED

Jan 19, 2022 GNRT

NON-FINAL ACTION WRITTEN

Jan 19, 2022 CNRT

ASSIGNED TO EXAMINER

Jan 13, 2022 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Aug 11, 2021 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 10, 2021 NWOS

NEW APPLICATION ENTERED

May 13, 2021 NWAP

Related Trademarks

More from this Owner

REISTONE BIOPHARMA

More in Same Class